Levodopa/benserazide
< Levodopa
| Combination of | |
|---|---|
| Levodopa | Dopamine agonist |
| Benserazide | Decarboxylase inhibitors |
| Clinical data | |
| Trade names | Prolopa, Madopar, others |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.